Compare AUTL & TSAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AUTL | TSAT |
|---|---|---|
| Founded | 2014 | 1969 |
| Country | United Kingdom | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 433.8M | 390.1M |
| IPO Year | 2025 | 2021 |
| Metric | AUTL | TSAT |
|---|---|---|
| Price | $1.69 | $32.93 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 104.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 28.33 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,120,000.00 | N/A |
| Revenue This Year | $670.78 | N/A |
| Revenue Next Year | $80.13 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 496.00 | N/A |
| 52 Week Low | $1.11 | $14.81 |
| 52 Week High | $2.70 | $36.85 |
| Indicator | AUTL | TSAT |
|---|---|---|
| Relative Strength Index (RSI) | 55.47 | 61.26 |
| Support Level | $1.65 | $28.22 |
| Resistance Level | $1.69 | $36.81 |
| Average True Range (ATR) | 0.11 | 2.13 |
| MACD | 0.03 | 0.62 |
| Stochastic Oscillator | 51.99 | 81.26 |
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
Telesat Corp is a satellite operator, that provides its customers with mission-critical communications services. It operates in a single operating segment, in which it provides satellite-based services to its broadcast, enterprise, and consulting customers around the world. Geographically, it derives a majority of its revenue from Canada. It derives revenue from Broadcast, Enterprise, Consulting, and others.